We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LIPO market cap is 3.22M. The company's latest EPS is USD -3.8208 and P/E is -0.69.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 104k | 121k | 146k | 136k | 81k |
| Operating Income | -1.36M | -730k | -1.22M | -952k | -1.46M |
| Net Income | -1.32M | -689k | -1.19M | -938k | -1.44M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 962k | 259k | 184k | 450k |
| Operating Income | -57k | -1.92M | -2.59M | -4.75M |
| Net Income | -62k | -1.87M | -2.6M | -4.62M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 2.84M | 3.58M | 3.14M | 2.18M | 2.16M |
| Total Liabilities | 619k | 433k | 576k | 480k | 701k |
| Total Equity | 2.22M | 3.14M | 2.56M | 1.7M | 1.46M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 955k | 2.01M | 5.95M | 3.58M |
| Total Liabilities | 492k | 589k | 1.27M | 433k |
| Total Equity | 463k | 1.42M | 4.68M | 3.14M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -2.42M | -3.15M | -1.39M | -2.31M | -2.96M |
| Investing | -14k | -14k | N/A | N/A | N/A |
| Financing | -275k | 1.34M | 200k | 200k | 1.02M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28k | -989k | -1.83M | -3.15M |
| Investing | N/A | -301k | 301k | -14k |
| Financing | 609k | 2.1M | 5.24M | 1.34M |
| Market Cap | 3.22M |
| Price to Earnings Ratio | -0.69 |
| Price to Sales Ratio | 7.07 |
| Price to Cash Ratio | 0.97 |
| Price to Book Ratio | 1.01 |
| Dividend Yield | - |
| Shares Outstanding | 1.21M |
| Average Volume (1 week) | 33.93k |
| Average Volume (1 Month) | 166.66k |
| 52 Week Change | -66.75% |
| 52 Week High | 12.00 |
| 52 Week Low | 2.21 |
| Spread (Intraday) | 0.08 (2.93%) |
| Company Name | Lipella Pharmaceuticals Inc |
| Address |
108 west 13th street wilmington, delaware 19801 |
| Website | https://www.lipella.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
